TH and glaucoma: 3-T1AM, an endogenous TH derivative, exhibits anti-inflammatory and neuroprotective properties by inhibiting pro-inflammatory cytokine release, reducing microglia-mediated inflammation, and mitigating oxidative stress [358], making it a potential candidate for glaucoma, myopia, DR, AMD, uveitis, and TAO.